Veranika Razhkova

Veranika Razhkova is a Principal on the Therapeutics team and provides extensive research and analysis on early-stage investments. Prior to joining the Therapeutics team, Ms. Razhkova worked on patient forecasting in the Deerfield Institute. She joined the Firm in 2015 as a Fellow. Ms. Razhkova holds a B.A. in Natural Sciences from The City University of New York’s Baruch College and M.S. in Biotechnology from Johns Hopkins University.

Veranika enjoys hiking nature trails, oil painting, and theater.